검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-8 · 마지막 7월 21일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | biologics treatment |
Overview Company | Merck KGaA, Darmstadt, Germany |
Overview Modality | ANTIBODY |
Overview Target | Psoriasis |
Overview Indication | Psoriasis; Psoriasis Arthritis |
Overview Phase | APPROVED |
Overview Status | RECRUITING |
MoA Biomarker | eGFR, high |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse |
PK/PD Experiment | PK |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse |
Toxicology Major finding | Long-term efficacy and safety of different biologics in treatment of chronic rhinosinusitis with nasal polyps: A network meta-analysis.. Direct comparison of the long-term effectiveness and safety of biologics for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is lacking. The study aimed to compare the long-term efficacy and safety of various biologics in the management of CRSwNP. The PubMed, E… |
Clinical Primary efficacy | ORR 11.11% |
Clinical ORR | 11.11% |
Clinical Result source | ClinicalTrials.gov NCT04458922 |
Clinical Data Tier / Score | A · 46 |
Clinical Program phase | APPROVED |
Clinical Clinical sync | 2026년 7월 18일 (8일 전) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-8 · 마지막 7월 21일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | biologics treatment |
Overview Company | Merck KGaA, Darmstadt, Germany |
Overview Modality | ANTIBODY |
Overview Target | Psoriasis |
Overview Indication | Psoriasis; Psoriasis Arthritis |
Overview Phase | APPROVED |
Overview Status | RECRUITING |
MoA Biomarker | eGFR, high |
PK/PD Species | Mouse |
PK/PD Animal (cat.) | Mouse |
PK/PD Experiment | PK |
Toxicology Species | Mouse |
Toxicology Animal (cat.) | Mouse |
Toxicology Major finding | Long-term efficacy and safety of different biologics in treatment of chronic rhinosinusitis with nasal polyps: A network meta-analysis.. Direct comparison of the long-term effectiveness and safety of biologics for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is lacking. The study aimed to compare the long-term efficacy and safety of various biologics in the management of CRSwNP. The PubMed, E… |
Clinical Primary efficacy | ORR 11.11% |
Clinical ORR | 11.11% |
Clinical Result source | ClinicalTrials.gov NCT04458922 |
Clinical Data Tier / Score | A · 46 |
Clinical Program phase | APPROVED |
Clinical Clinical sync | 2026년 7월 18일 (8일 전) |
추천 비교
추천 비교